Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells

Life Sciences

Volumn 89, Issue 25-26, 2011, Pages 939-945

  Jiménez Aliaga, Karim ^a   Bermejo Bescós, Paloma ^a   Benedí, Juana ^a   Martín Aragón, Sagrario ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Antiamyloidogenic; APPswe; Glutathione; Lipid peroxidation; Quercetin; Rutin

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; GLUTATHIONE; QUERCETIN; REACTIVE OXYGEN METABOLITE; RUTOSIDE; AMYLOID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (25 35); AMYLOID BETA-PROTEIN (25-35); ANTIOXIDANT; HYDROGEN PEROXIDE; PEPTIDE FRAGMENT; SECRETASE;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; NEUROTOXICITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; DOSE RESPONSE; DRUG EFFECT; METABOLISM; NEUROBLASTOMA; TUMOR CELL LINE;

AMYLOID; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ANTIOXIDANTS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; NEUROBLASTOMA; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; QUERCETIN; REACTIVE OXYGEN SPECIES; RUTIN;

EID: 84855730408     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.09.023     Document Type: Article

References (44)

1. An Y, Qi XL, Pei JJ, Tang Z, Xiao Y, Guan ZZ. Amyloid precursor protein gene mutated at Swedish 670/671 sites in vitro induces changed expression of nicotinic acetylcholine receptors and neurotoxicity. Neurochem Int 2010;57(6):647-54.
2. Arora A, Byrem TM, Nair MG, Strasburg GM. Modulation of liposomal membrane fluidity by flavonoids and isoflavonoids. Arch Biochem Biophys 2000;373(1):102-9.
3. Arredondo F, Echeverry C, Abin-Carriquiry JA, Blasina F, Antunez K, Jones DP, et al. After cellular internalization, quercetin causes Nrf2 nuclear translocation, increases glutathione levels, and prevents neuronal death against an oxidative insult. Free Radic Biol Med 2010;49(5):738-47.
4. Bastianetto S, Krantic S, Quirion R. Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease. Mini Rev Med Chem 2008;8(5):429-35.
5. Bermejo P, Martin-Aragon S, Benedi J, Susin C, Felici E, Gil P, et al. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from mild cognitive impairment Free Radic Res 2008;42(2):162-70.
6. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet 2006;368(9533): 387-403.
7. Braak H, de Vos RA, Jansen EN, Bratzke H, Braak E. Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. Prog Brain Res 1998;117:267-85.
8. Choquenet B, Couteau Cl, Paparis E, Coiffard LJM. Quercetin and rutin as potential sunscreen agents: determination of efficacy by an in vitro method. J Nat Prod 2008;71 (6):1117-8.
9. Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-Gateau P, Dartigues JF. Intake of flavonoids and risk of dementia. Eur J Epidemiol 2000;16(4):357-63.
10. D'Ursi AM, Armenante MR, Guerrini R, Salvadori S, Sorrentino G, Picone D. Solution structure of amyloid beta-peptide (25-35) in different media. J Med Chem 2004;47(17):4231-8.
11. Eckert A, Steiner B, Marques C, Leutz S, Romig H, Haass C, et al. Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation. J Neurosci Res 2001;64(2):183-92.
12. Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 2008;15(6):558-66.
13. Guo T, Hobbs DW. Development of BACE1 inhibitors for Alzheimer's disease. Curr Med Chem 2006;13(15):1811-29.
14. Haass C. Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J 2004;23(3):483-8.
15. Heo HJ, Kim DO, Choi SJ, Shin DH, Lee CY Potent inhibitory effect of flavonoids in Scutellaria baicalensis on amyloid beta protein-induced neurotoxicity. J Agric Food Chem 2004;52 (13):4128-32.
16. Keil U, Bonert A, Marques CA, Strosznajder JB, Muller-Spahn F, Muller WE, et al. Elevated nitric oxide production mediates beta-amyloid-induced mitochondria failure. Pol J Pharmacol 2004;56(5):631-4.
17. Khodarahmi R, Beyrami M, Soori H. Appraisal of casein's inhibitory effects on aggregation accompanying carbonic anhydrase refolding and heat-induced ovalbumin fibrillogenesis. Arch Biochem Biophys 2008;477(1):67-76.
18. Kihara T, Shimohama S, Sawada H, Honda K, Nakamizo T, Shibasaki H, et al. alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J Biol Chem 2001;276(17):13541-6.
19. Kim DO, Lee CY. Comprehensive study on vitamin C equivalent antioxidant capacity (VCEAC) of various polyphenolics in scavenging a free radical and its structural relationship. Crit Rev Food Sci Nutr 2004;44(4):253-73.
20. Kim H, Park BS, Lee KG, Choi CY, Jang SS, Kim YH, et al. Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J Agric Food Chem 2005;53(22):8537-41.
21. Ko PC, Kilduff PT, Higgens JA, Milberg W, McGlinchey R. Evidence for intact selective attention in Alzheimer's disease patients using a location priming task. Neuropsychology 2005;19(3):381-9.
22. Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc Natl Acad Sci U S A 2001;98(10):5815-20.
23. LeBel CP, Ischiropoulos H, Bondy SC. Evaluation of the probe 2′, 7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992;5(2):227-31.
24. Liu H, Wang H, Shenvi S, Hagen TM, Liu RM. Glutathione metabolism during aging and in Alzheimer disease. Ann N Y Acad Sci 2004;1019:346-9.
25. Lundkvist J, Naslund J. Gamma-secretase: a complex target for Alzheimer's disease. Curr Opin Pharmacol 2007;7(1):112-8.
26. Marques CA, Keil U, Bonert A, Steiner B, Haass C, Muller WE, et al. Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. J Biol Chem 2003;278(30):28294-302.
27. Misonou H, Morishima-Kawashima M, Ihara Y. Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. Biochemistry 2000;39(23):6951-9.
28. Omololu PA, Rocha JBT, Kade IJ. Attachment of rhamnosyl glucoside on quercetin confers potent iron-chelating ability on its antioxidant properties. Exp Toxicol Pathol 2011;63(3):249-55.
29. Ono K, Hamaguchi T, Naiki H, Yamada M. Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer's disease. Biochim Biophys Acta 2006;1762(6):575-86.
30. Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW. Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem 1995;64(1):253-65.
31. Porat Y, Mazor Y, Efrat S, Gazit E. Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions. Biochemistry 2004;43(45):14454-62.
32. Resende R, Moreira PI, Proenca T, Deshpande A, Busciglio J, Pereira C, et al. Brain oxida-tive stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 2008;44(12):2051-7.
33. Riviere C, Richard T, Vitrac X, Merillon JM, Valls J, Monti JP. New polyphenols active on beta-amyloid aggregation. Bioorg Med Chem Lett 2008;18(2):828-31.
34. Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS, et al. BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet 2001;10 (12):1317-24.
35. Salloway S, Mintzer J, Weiner MF, Cummings JL. Disease-modifying therapies in Alzheimer's disease. Alzheimers Dement 2008;4(2):65-79.
36. Senft AP, Dalton TP, Shertzer HG. Determining glutathione and glutathione disulfide using the fluorescence probe o-phthalaldehyde. Anal Biochem 2000;280(1):80-6.
37. Shimmyo Y, Kihara T, Akaike A, Niidome T, Sugimoto H.Flavonols and flavonesas BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. Biochim Biophys Acta (BBA)-Gen Subj 2008;1780(5):819-25.
38. Sternberg Z, Chadha K, Lieberman A, Hojnacki D, Drake A, Zamboni P, et al. Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients. J Neuroimmunol 2008;205(1-2):142-7.
39. Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, et al. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci U S A 2006;103(49):18727-32.
40. Torel J, Cillard J, Cillard P. Antioxidant activity of flavonoids and reactivity with peroxy radical. Phytochemistry 1986;25(2):383-5.
41. von Arnim CA, von Einem B, Weber P, Wagner M, Schwanzar D, Spoelgen R, et al. Impact of cholesterol level upon APP and BACE proximity and APP cleavage. Biochem Biophys Res Commun 2008;370(2):207-12.
42. Wach A, Pyrzynska K, Biesaga M. Quercetin content in some food and herbal samples. Food Chem 2007;100(2):699-704.
43. Weinreb O, Mandel S, Amit T, Youdim MBH. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. J Nutr Biochem 2004;15(9):506-16.
44. Zhang Q, Yang G, Li W, Fan Z, Sun A, Luo J, et al. Thiamine deficiency increases beta-secretase activity and accumulation of beta-amyloid peptides. Neurobiol Aging 2011;32(1): 42-53.